ELEVANCE HEALTH INC (ELV) Scores Highest on Martin Zweig's Growth Investor Model with a 69% Rating.

viernes, 28 de noviembre de 2025, 4:08 pm ET1 min de lectura
ELV--

Elevance Health Inc (ELV) scores 69% using Martin Zweig's Growth Investor model, which looks for stocks with accelerating earnings and sales growth, reasonable valuations, and low debt. ELV passes tests on P/E ratio, revenue growth in relation to EPS growth, current quarter earnings, quarterly earnings one year ago, EPS growth for current quarter, and earnings persistence. However, it fails tests on sales growth rate, earnings growth rate for the past several quarters, long-term EPS growth, and insider transactions.

ELEVANCE HEALTH INC (ELV) Scores Highest on Martin Zweig's Growth Investor Model with a 69% Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios